Showing codes J9325 (Injection, talimogene laherparepvec, per 1 million plaque forming units) — J9393 (Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg)

J9325 - Inj talimogene laherparepvec
Long description: Injection, talimogene laherparepvec, per 1 million plaque forming units
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9328 - Temozolomide injection
Long description: Injection, temozolomide, 1 mg
Code added date: 20100101.
Code effective date: 20100101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9330 - Temsirolimus injection
Long description: Injection, temsirolimus, 1 mg
Code added date: 20090101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9331 - Inj sirolimus prot part 1 mg
Long description: Injection, sirolimus protein-bound particles, 1 mg
Code added date: 20220701.
Code effective date: 20220701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9332 - Inj efgartigimod 2mg
Long description: Injection, efgartigimod alfa-fcab, 2mg
Code added date: 20220701.
Code effective date: 20220701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9333 - Inj ronzanolixizum-noli 1 mg
Long description: Injection, rozanolixizumab-noli, 1 mg
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9334 - Inj efgart-alfa 2mg hya-qvfc
Long description: Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9340 - Thiotepa injection
Long description: Injection, thiotepa, 15 mg
Code added date: 19840101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9345 - Inj, retifanlimab-dlwr, 1 mg
Long description: Injection, retifanlimab-dlwr, 1 mg
Code added date: 20231001.
Code effective date: 20231001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9347 - Inj, tremelimumab-actl, 1 mg
Long description: Injection, tremelimumab-actl, 1 mg
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9348 - Inj. naxitamab-gqgk, 1 mg
Long description: Injection, naxitamab-gqgk, 1 mg
Code added date: 20210701.
Code effective date: 20210701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9349 - Inj., tafasitamab-cxix
Long description: Injection, tafasitamab-cxix, 2 mg
Code added date: 20210401.
Code effective date: 20210401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9350 - Inj mosunetuzumab-axgb, 1 mg
Long description: Injection, mosunetuzumab-axgb, 1 mg
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9351 - Topotecan injection
Long description: Injection, topotecan, 0.1 mg
Code added date: 20110101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9352 - Injection trabectedin 0.1mg
Long description: Injection, trabectedin, 0.1 mg
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9353 - Inj. margetuximab-cmkb, 5 mg
Long description: Injection, margetuximab-cmkb, 5 mg
Code added date: 20210701.
Code effective date: 20210701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9354 - Inj, ado-trastuzumab emt 1mg
Long description: Injection, ado-trastuzumab emtansine, 1 mg
Code added date: 20140101.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9355 - Inj trastuzumab excl biosimi
Long description: Injection, trastuzumab, excludes biosimilar, 10 mg
Code added date: 20000101.
Code effective date: 20190701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9356 - Inj. herceptin hylecta, 10mg
Long description: Injection, trastuzumab, 10 mg and hyaluronidase-oysk
Code added date: 20190701.
Code effective date: 20190701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9357 - Valrubicin injection
Long description: Injection, valrubicin, intravesical, 200 mg
Code added date: 20000101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9358 - Inj fam-trastu deru-nxki 1mg
Long description: Injection, fam-trastuzumab deruxtecan-nxki, 1 mg
Code added date: 20200701.
Code effective date: 20200701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9359 - Inj lon tesirin-lpyl 0.075mg
Long description: Injection, loncastuximab tesirine-lpyl, 0.075 mg
Code added date: 20220401.
Code effective date: 20220401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9360 - Vinblastine sulfate inj
Long description: Injection, vinblastine sulfate, 1 mg
Code added date: 19860101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9361 - Inj, efbemalenograstim alfa-
Long description: Injection, efbemalenograstim alfa-vuxw, 0.5 mg
Code added date: 20240701.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9370 - Vincristine sulfate 1 mg inj
Long description: Vincristine sulfate, 1 mg
Code added date: 19860101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9371 - Inj, vincristine sul lip 1mg
Long description: Injection, vincristine sulfate liposome, 1 mg
Code added date: 20140101.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9376 - Inj pozelimab-bbfg, 1 mg
Long description: Injection, pozelimab-bbfg, 1 mg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9380 - Inj teclistamab cqyv 0.5 mg
Long description: Injection, teclistamab-cqyv, 0.5 mg
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9381 - Inj teplizumab mzwv 5 mcg
Long description: Injection, teplizumab-mzwv, 5 mcg
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9390 - Vinorelbine tartrate inj
Long description: Injection, vinorelbine tartrate, 10 mg
Code added date: 19960101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9393 - Inj, fulvestrant (teva)
Long description: Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg
Code added date: 20230101.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF